Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Advancis' Amoxicillin Pulsys Fails In Second Phase III Trial

July 25, 2005

By Jennifer Boggs

Dendreon Rises On Provenge Survival Data; Considers BLA

July 22, 2005

By Jennifer Boggs

Dendreon Rises On Provenge Survival Data; Considers BLA

July 22, 2005

By Jennifer Boggs

EPIX's Phase II Trial Delayed For Blood Clot Imaging Agent

July 21, 2005

By Jennifer Boggs

EPIX's Phase II Trial Delayed For Blood Clot Imaging Agent

July 21, 2005

By Jennifer Boggs

Ilypsa's Series B Adds $36M For Renal Disease Products

July 20, 2005

By Jennifer Boggs

Ilypsa's Series B Adds $36M For Renal Disease Products

July 20, 2005

By Jennifer Boggs

CombinatoRx Out-Licenses Oncology Drug To HenKan

July 19, 2005

By Jennifer Boggs

CombinatoRx Out-Licenses Oncology Drug To HenKan

July 19, 2005

By Jennifer Boggs

BrainCells' Neurogenesis Work Brings In $17.7M In First Round

July 18, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 17, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.